Gestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthood

由 Stapleton, P. A.
發表在 J Physiol (2015)

Considering Intrauterine Location in a Model of Fetal Growth Restriction After Maternal Titanium Dioxide Nanoparticle Inhalation

由 D'Errico, J. N., Fournier, S. B., Stapleton, P. A.
發表在 Front Toxicol (2021)

Engineered nanomaterial applications in perinatal therapeutics

由 Fournier, S.B., D’Errico, J.N., Stapleton, P.A.
發表在 Pharmacol Res (2018)

Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure

由 Fournier, S. B., Kallontzi, S., Fabris, L., Love, C., Stapleton, P. A.
發表在 Cardiovasc Toxicol (2019)

Uterine microvascular sensitivity to nanomaterial inhalation: An in vivo assessment()

由 Stapleton, P.A., McBride, C.R., Yi, J., Nurkiewicz, T.R.
發表在 Toxicol Appl Pharmacol (2015)

Estrous cycle-dependent modulation of in vivo microvascular dysfunction after nanomaterial inhalation

由 Stapleton, P.A., McBride, C.R., Yi, J., Abukabda, A.B., Nurkiewicz, T.R.
發表在 Reprod Toxicol (2018)

Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome

由 Stapleton, P. A., Hathaway, Q. A., Nichols, C. E., Abukabda, A. B., Pinti, M. V., Shepherd, D. L., McBride, C. R., Yi, J., Castranova, V. C., Hollander, J. M., Nurkiewicz, T. R.
發表在 Part Fibre Toxicol (2018)